These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group. Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104 [Abstract] [Full Text] [Related]
24. Trends in hospitalization rates for inflammatory bowel disease in the United States. Bewtra M, Su C, Lewis JD. Clin Gastroenterol Hepatol; 2007 May; 5(5):597-601. PubMed ID: 17382602 [Abstract] [Full Text] [Related]
25. Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases. Newby EA, Croft NM, Green M, Hassan K, Heuschkel RB, Jenkins H, Casson DH. J Pediatr Gastroenterol Nutr; 2008 May; 46(5):539-45. PubMed ID: 18493209 [Abstract] [Full Text] [Related]
30. Smoking and inflammatory bowel disease in families. Smith MB, Lashner BA, Hanauer SB. Am J Gastroenterol; 1988 Apr; 83(4):407-9. PubMed ID: 3348193 [Abstract] [Full Text] [Related]
31. Inflammatory bowel diseases: controversies in the use of diagnostic procedures. Vucelic B. Dig Dis; 2009 Apr; 27(3):269-77. PubMed ID: 19786751 [Abstract] [Full Text] [Related]
32. Epidemiological aspects of inflammatory bowel disease in the Pamplona area. Arin Letamendia A, Burusco Paternain MJ, Borda Celaya F, Pueyo Royo A, Martínez Echeverría A, Jiménez Pérez FJ. Rev Esp Enferm Dig; 1999 Nov; 91(11):769-76. PubMed ID: 10601770 [Abstract] [Full Text] [Related]
33. [Does smoking influence the course of Crohn's disease in patients with the presence of gene NOD2/CARD15 mutation?]. Dobrowolska-Zachwieja A, Kaczmarek M, Hoppe-Gołebiewska J, Kalak R, Słomski R, Linke K. Pol Merkur Lekarski; 2005 May; 18(107):560-5. PubMed ID: 16161956 [Abstract] [Full Text] [Related]
34. Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic bowel disease. Tremaine WJ, Timmons LJ, Loftus EV, Pardi DS, Sandborn WJ, Harmsen WS, Thapa P, Zinsmeister AR. Aliment Pharmacol Ther; 2007 Jun 15; 25(12):1435-41. PubMed ID: 17539983 [Abstract] [Full Text] [Related]
35. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases]. Mokrowiecka A, Gasiorowska A, Małecka-Panas E. Pol Merkur Lekarski; 2004 Jun 15; 17 Suppl 1():22-6. PubMed ID: 15603341 [Abstract] [Full Text] [Related]
37. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J, Hungarian IBD Study Group, Lakatos PL. Am J Gastroenterol; 2008 Mar 15; 103(3):665-81. PubMed ID: 18047543 [Abstract] [Full Text] [Related]
38. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role. Parente F, Cucino C, Bollani S, Imbesi V, Maconi G, Bonetto S, Vago L, Bianchi Porro G. Am J Gastroenterol; 2000 Mar 15; 95(3):705-11. PubMed ID: 10710061 [Abstract] [Full Text] [Related]
39. [Smoking and ovulation inhibitor in inflammatory bowel diseases]. Katschinski B. Med Klin (Munich); 1993 Feb 15; 88 Suppl 1():5-8. PubMed ID: 8464399 [Abstract] [Full Text] [Related]
40. Smoking and disease recurrence after operation for Crohn's disease. Yamamoto T, Keighley MR. Br J Surg; 2000 Apr 15; 87(4):398-404. PubMed ID: 10759731 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]